Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1-dichloroethene | decreases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of ADGRF5 mRNA | CTD | PMID:26682919 | 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of ADGRF5 mRNA | CTD | PMID:30723492 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of ADGRF5 mRNA | CTD | PMID:20068009 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Adgrf5 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Adgrf5 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ADGRF5 mRNA | CTD | PMID:19465110 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ADGRF5 mRNA | CTD | PMID:34747641 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of ADGRF5 mRNA | CTD | PMID:21346803 | 2-palmitoylglycerol | increases expression | ISO | ADGRF5 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of ADGRF5 mRNA | CTD | PMID:37199045 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of ADGRF5 mRNA | CTD | PMID:26251327 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | ADGRF5 (Homo sapiens) | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADGRF5 mRNA | CTD | PMID:16997883 | 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of ADGRF5 mRNA | CTD | PMID:30723492 | 4,4'-sulfonyldiphenol | increases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | bisphenol S results in increased expression of ADGRF5 mRNA | CTD | PMID:30951980 | 8-Br-cAMP | multiple interactions | ISO | ADGRF5 (Homo sapiens) | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADGRF5 mRNA | CTD | PMID:16997883 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of ADGRF5 mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases methylation | ISO | ADGRF5 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of ADGRF5 gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | ISO | ADGRF5 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of ADGRF5 mRNA | CTD | PMID:21934132 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ADGRF5 mRNA | CTD | PMID:16483693 | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of ADGRF5 mRNA | CTD | PMID:30779732 | arsenous acid | decreases expression | ISO | ADGRF5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of ADGRF5 mRNA | CTD | PMID:26705709 | benzo[a]pyrene | increases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of ADGRF5 mRNA | CTD | PMID:21964900 and PMID:32417428 | benzo[a]pyrene | increases expression | ISO | ADGRF5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of ADGRF5 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | increases methylation | ISO | ADGRF5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ADGRF5 promoter | CTD | PMID:27901495 | benzo[b]fluoranthene | increases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of ADGRF5 mRNA | CTD | PMID:26377693 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ADGRF5 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ADGRF5 mRNA | CTD | PMID:30816183 | bisphenol A | increases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | bisphenol A results in increased expression of ADGRF5 mRNA | CTD | PMID:30951980 and PMID:32156529 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of ADGRF5 gene | CTD | PMID:28505145 | bisphenol F | increases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | bisphenol F results in increased expression of ADGRF5 mRNA | CTD | PMID:30951980 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of ADGRF5 promoter | CTD | PMID:22457795 | carbon nanotube | decreases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of ADGRF5 mRNA | CTD | PMID:25554681 | carbon nanotube | increases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of ADGRF5 mRNA | CTD | PMID:25620056 | carbon nanotube | affects expression | ISO | Adgrf5 (Mus musculus) | 6480464 | Nanotubes and Carbon affects the expression of ADGRF5 mRNA | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | ADGRF5 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ADGRF5 gene] | CTD | PMID:28238834 | chlordecone | increases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | Chlordecone results in increased expression of ADGRF5 mRNA | CTD | PMID:33711761 | chlorpyrifos | increases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of ADGRF5 mRNA | CTD | PMID:37019170 | ciguatoxin CTX1B | affects expression | ISO | Adgrf5 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of ADGRF5 mRNA | CTD | PMID:18353800 | clothianidin | decreases expression | ISO | ADGRF5 (Homo sapiens) | 6480464 | clothianidin results in decreased expression of ADGRF5 mRNA | CTD | PMID:31626844 | cobalt dichloride | decreases expression | ISO | ADGRF5 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of ADGRF5 mRNA | CTD | PMID:19320972 | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of ADGRF5 mRNA | CTD | PMID:30556269 | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of ADGRF5 mRNA | CTD | PMID:30556269 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of ADGRF5 mRNA | CTD | PMID:23640034 | dexamethasone | multiple interactions | ISO | ADGRF5 (Homo sapiens) | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADGRF5 mRNA | CTD | PMID:16997883 | dextran sulfate | multiple interactions | ISO | Adgrf5 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRF5 mRNA | CTD | PMID:29950665 | diarsenic trioxide | decreases expression | ISO | ADGRF5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of ADGRF5 mRNA | CTD | PMID:26705709 | doxorubicin | decreases expression | ISO | ADGRF5 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ADGRF5 mRNA | CTD | PMID:29803840 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of ADGRF5 mRNA | CTD | PMID:29391264 | fipronil | increases expression | EXP | | 6480464 | fipronil results in increased expression of ADGRF5 mRNA | CTD | PMID:23962444 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of ADGRF5 mRNA | CTD | PMID:22061828 and PMID:33387578 | isoprenaline | increases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of ADGRF5 mRNA | CTD | PMID:20003209 | levonorgestrel | multiple interactions | ISO | ADGRF5 (Homo sapiens) | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ADGRF5 mRNA | CTD | PMID:19074003 | methamphetamine | increases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | Methamphetamine results in increased expression of ADGRF5 mRNA | CTD | PMID:26307267 | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of ADGRF5 gene | CTD | PMID:33148267 | N-Nitrosopyrrolidine | decreases expression | ISO | ADGRF5 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in decreased expression of ADGRF5 mRNA | CTD | PMID:32234424 | nevirapine | increases expression | EXP | | 6480464 | Nevirapine metabolite results in increased expression of ADGRF5 mRNA | CTD | PMID:23947594 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of ADGRF5 mRNA | CTD | PMID:25729387 | oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of ADGRF5 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | Adgrf5 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ADGRF5 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ADGRF5 mRNA | CTD | PMID:34911549 | paracetamol | affects expression | ISO | Adgrf5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of ADGRF5 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ADGRF5 mRNA | CTD | PMID:33387578 | paracetamol | increases expression | ISO | ADGRF5 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of ADGRF5 mRNA | CTD | PMID:26690555 | PCB138 | multiple interactions | ISO | Adgrf5 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | perfluorooctane-1-sulfonic acid | increases expression | ISO | ADGRF5 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in increased expression of ADGRF5 mRNA | CTD | PMID:32588087 | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of ADGRF5 gene | CTD | PMID:33148267 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of ADGRF5 mRNA | CTD | PMID:28374803 | testosterone undecanoate | multiple interactions | ISO | ADGRF5 (Homo sapiens) | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ADGRF5 mRNA | CTD | PMID:19074003 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of ADGRF5 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of ADGRF5 mRNA | CTD | PMID:23557971 | titanium dioxide | multiple interactions | ISO | Adgrf5 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRF5 mRNA | CTD | PMID:29950665 | titanium dioxide | decreases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of ADGRF5 mRNA | CTD | PMID:29264374 | toluene | increases expression | EXP | | 6480464 | Toluene results in increased expression of ADGRF5 mRNA | CTD | PMID:22967744 | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of ADGRF5 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of ADGRF5 mRNA | CTD | PMID:25729387 | triadimefon | increases expression | ISO | ADGRF5 (Homo sapiens) | 6480464 | triadimefon results in increased expression of ADGRF5 mRNA | CTD | PMID:26705709 | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of ADGRF5 gene | CTD | PMID:27618143 | trichostatin A | decreases expression | ISO | ADGRF5 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of ADGRF5 mRNA | CTD | PMID:26705709 | trimellitic anhydride | decreases expression | ISO | Adgrf5 (Mus musculus) | 6480464 | trimellitic anhydride results in decreased expression of ADGRF5 mRNA | CTD | PMID:19042947 | valproic acid | decreases methylation | ISO | ADGRF5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of ADGRF5 gene | CTD | PMID:29154799 | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of ADGRF5 mRNA | CTD | PMID:29427782 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ADGRF5 mRNA | CTD | PMID:29427782 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of ADGRF5 mRNA | CTD | PMID:19015723 | |